Kalydeco | search
Click here to view Kalydeco news from 60+ newspapers.
Bookmark or Share- How Does Kalydeco (Ivacaftor) Treat Cystic Fibrosis?Kalydeco® (ivacaftor) is approved to treat cystic fibrosis (CF) in people with one of 97 different kinds of CFTR mutations. It can be used by people with CF who are 4 months and older. 1. Cystic fibrosis (CF) is a genetically inherited disease that causes recurring lung infections and gastrointestinal issues that gradually damage many organs.
- KALYDECO® (ivacaftor) | Patient InformationKALYDECO is a prescription medicine used for the treatment of cystic fibrosis (CF) in people aged 1 month and older who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to KALYDECO.
- Ivacaftor - WikipediaIvacaftor is a medication used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (primarily the G551D mutation), who account for 4–5% cases of cystic fibrosis. [ 5 ][ 6 ] It is also included in combination medications, lumacaftor/ivacaftor, tezacaftor/ivacaftor, and e...
- Kalydeco (Ivacaftor): Side Effects, Uses, Dosage, Interactions ... - RxListKALYDECO is a prescription medicine used for the treatment of cystic fibrosis (CF) in people aged 1 month and older who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR gene) that is responsive to KALYDECO.
- How KALYDECO® (ivacaftor) WorksKALYDECO is a prescription medicine used for the treatment of cystic fibrosis (CF) in people aged 1 month and older who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to KALYDECO.
More
